Now showing items 61-70 of 245
Optimization of multi‐stage dynamic treatment regimes utilizing accumulated data
(Plenum PublishingWiley Periodicals, Inc., 2015-11-20)
A Dirichlet process mixture model for survival outcome data: assessing nationwide kidney transplant centers
(Wiley Periodicals, Inc.Springer, 2015-04-15)
Propensity score‐based diagnostics for categorical response regression models
(John Wiley & Sons, Inc., 2014-02-10)
A robust weighted Kaplan–Meier approach for data with dependent censoring using linear combinations of prognostic covariates
(John Wiley & Sons, Ltd., 2010-09-20)
The weighted Kaplan–Meier (WKM) estimator is often used to incorporate prognostic covariates into survival analysis to improve efficiency and correct for potential bias. In this paper, we generalize the WKM estimator to ...
Search & Discovery (Spring, 2008)
(University of Michigan, Office of the Vice President for Research, 2008)
Mixture cure model with random effects for the analysis of a multi-center tonsil cancer study
(John Wiley & Sons, Ltd., 2011-02-10)
Cure models for clustered survival data have the potential for broad applicability. In this paper, we consider the mixture cure model with random effects and propose several estimation methods based on Gaussian quadrature, ...
Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates
(Wiley Periodicals, Inc.Springer‐Verlag, 2014-12-30)
A risk-adjusted CUSUM in continuous time based on the Cox model
(John Wiley & Sons, Ltd., 2008-07-30)
There was a mistake in the contact information of the second author in the above paper (DOI: 10.1002/sim.3216 ). The correct affiliation is shown above. We apologise for the error and any inconvenience caused.
Balanced centralized and distributed database design in a clinical research environment
(John Wiley & Sons, Ltd., 2000-06-15)
Clinical research databases can meet both research and clinical needs, but this ideal is seldom achieved. Priorities often differ for those who collect and ultimately use the data and those who develop data systems. ...
Intention‐to‐treat analysis with treatment discontinuation and missing data in clinical trials
(The National Academies PressWiley Periodicals, Inc., 2015-07-20)